# Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]

> **NCT05870566** · NA · RECRUITING · sponsor: **Claus Cursiefen** · enrollment: 110 (estimated)

## Conditions studied

- Corneal Transplantation

## Interventions

- **DEVICE:** Corneal Crosslinking

## Key facts

- **NCT ID:** NCT05870566
- **Lead sponsor:** Claus Cursiefen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-20
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2024-10-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05870566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05870566, "Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05870566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*